Abstract:
Miglitol an anti-diabetic drug has been shown to reduce plasma lipids and inhibit free radical generation. The anti-hyperlipidemic and antioxidant effect of miglitol were studied in triton induced hyperlipidemic rats and high fat diet fed obese rats. Plasma cholesterol and triglycerides levels were significantly lowered by miglitol at 100mg/kg body weight dose. Miglitol inhibited generation of superoxide anion and hydroxyl free radicals by 14 and 31% in enzymatic systems and 19 and 25% in non-enzymatic systems, respectively. In vitro effect of drug on adipogenesis using 3T3-L1 preadipocytes at 2, 5 and 10µM concentrations showed significant inhibition of adipogenesis (34.2%) at 10µM concentration. High fat diet fed rat model was used to investigate anti-hyperlipidemic, anti-obesity and antioxidant effect of miglitol. Miglitol increased the activities of lecithin-cholesterol-acyltransferase (19%), post heparin lipolytic activity (26%), lipoprotein lipase (26%) and triglyceride lipase (31%) which result in decrease in plasma lipid levels. The antioxidant enzymes viz., Catalase, Superoxide dismutase, glutathione peroxidase, glutathione reductase and thioredoxin reductase were increased by the drug in the treated animals. The antihyperlipidemic and antioxidant effect of miglitol can be correlated to its effect on different enzymes and it can be used for inhibiting the development of cardiovascular diseases.
